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In the present study, we investigated to the antioxidant and angiotensin I-converting enzyme (ACE) inhibitory
activities of the northern shrimp (Pandalus borealis) by-products (PBB) hydrolysates prepared by enzymatic
hydrolysis. The antioxidant and ACE inhibitory activities of five enzymatic hydrolysates (alcalase, protamex,
flavourzyme, papain, and trypsin) of PBB were evaluated by the 2, 2′-azino-bis [3-ethylbenzothiazoline-6-sulfonic
acid] (ABTS+) radical scavenging and superoxide dismutase (SOD)-like activities, reducing power and Li’s method for
ACE inhibitory activity. Of these PBB hydrolysates, the protamex hydrolysate exhibited the most potent ACE inhibitory
activity with IC50 value of 0.08 ± 0.00 mg/mL. The PBB protamex hydrolysate was fractionated by two ultrafiltration
membranes with 3 and 10 kDa (below 3 kDa, between 3 and 10 kDa, and above 10 kDa). These three fractions were
evaluated for the total amino acids composition, antioxidant, and ACE inhibitory activities. Among these fractions, the
< 3 kDa and 3–10 kDa fractions showed more potent ABTS+ radical scavenging activity than that of > 10 kDa fraction,
while the > 10 kDa fraction exhibited the significant reducing power than others. In addition, 3–10 kDa and > 10 kDa
fractions showed the significant ACE inhibitory activity. These results suggested that the high molecular weight
enzymatic hydrolysate derived from PBB could be used for control oxidative stress and prevent hypertension.
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Abbreviations: ACE, Angiotensin I converting enzyme; PBB, Pandalus borealis by-products; ABTS+, 2,2'-Azino-
bis[3-ethylbenzothiazoline-6-sulfonic acid]; SOD, Superoxide dismutase; RAS, Renin angiotensin system; OPA,
o-phthaldialdehyde; DMSO, Dimethyl sulfoxide; EDTA, Ethylenediaminetetraacetic acid; K3Fe(CN)6, Potassium
ferricyanide; TCA, Trichloroacetic acid; HHL, Hippuryl-L-histidyl-L-leucine; BSC, Benzene sulfonyl chloride;
FeCl3, Iron (III) chloride; MWCO, Molecular weight cut-offs; ROS, Reactive oxygen speciesBackground
Hypertension is one of the primary causes of cardiovascu-
lar disease which leads to stroke, coronary artery disease,
and sudden cardiac death (Bhuyan and Mugesh 2011).
The renin-angiotensin system (RAS) plays a key role in
regulating blood volume and hypertension (Hall 1991;
Hall et al. 1989). Angiotensin I-converting enzyme (ACE)
is important in the functioning of the RAS. Renin converts
angiotensinogen to angiotensin I, and ACE catalyzes
cleavage of angiotensin I into angiotensin II which is the* Correspondence: whasoo@korea.kr
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Takahashi et al. 2011). The increased angiotensin II causes
vasoconstriction along with increased blood volume and
water retention (Parish and Miller 1992). Several ACE in-
hibitors have been tested and developed in order to inhibit
angiotensin II-mediated hypertension. Most synthetic
ACE inhibitors such as captopril, enalapril, lisinopril,
ramipril, and benzapril on the market have been reported
with their side effects including skin rash, loss of taste,
and dry cough (Dr and Lisa 2012). Moreover, a recent re-
search has found that oxidative stress is a principal factor
for hypertension (Bagatini et al. 2011). Excess reactive
oxygen species affects cellular functions and reduces thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 The proximate compositions including moisture, crude
fat, ash, and crude protein of PBB
Moisture (%) Crude fat (%) Ash (%) Crude protein (%)
PBB 21.07 ± 0.22 12.19 ± 0.12 17.18 ± 0.64 44.50 ± 0.35
Protamex 7.05 ± 0.21 1.12 ± 0.15 18.35 ± 0.21 73.92 ± 0.95
< 3 K 14.04 ± 0.13 4.66 ± 0.21 15.85 ± 0.18 62.07 ± 3.23
3–10 K 7.26 ± 0.17 2.27 ± 0.25 11.75 ± 0.26 69.31 ± 2.11
> 10 K 5.48 ± 0.22 2.30 ± 0.17 12.69 ± 0.31 74.02 ± 2.63
The proximate composition of PBB was measured by AOAC methods
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low-density lipoprotein oxidation in the vascular system
(Ray et al. 2012; Toeroek 2008; Mattson 2009). Therefore,
there is a necessity for the development of new ACE in-
hibitors with potent oxidative stress inhibition and fewer
side effects from natural resources.
Northern shrimp (Pandalus borealis), one of the most
popular shrimp species in Korea, belongs to family
Pandalidae and distributes widely in the deep sea at
depths of 20–1330 m with a temperature of 2–14 °C
found in the water around the eastern coast of Korea
(Bauer 2004). This is rich in nutrients such as proteins,
minerals, and vitamins. However, the inedible parts of
shrimp by-products including head, shell, and tail portions
account for approximately 50 % of the catch and constitute
valuable and useful bioactive materials, such as caroteno-
protein, pigments, chitin, and chitosan (Chakrabarti 2002;
Babu et al. 2008; Younes et al. 2015). Recently, much
research has been carried out on the utilization of protein-
rich fisheries by-products as nutraceuticals and nutritional
supplements with high nutrient (Chae et al. 1998; Guerard
et al. 2001; Arvanitoyannis and Kassaveti 2008).
The aim of the present study was to determine antioxi-
dant and ACE inhibitory activities of enzymatic hydroly-
sates and its molecular weight cut-off fractions of the
P. borealis by-products for prevention of hypertension.
Methods
Materials
P. borealis was purchased from the market of Yang
yang-gun, Gangwon-do, Korea, in May, 2012. Alcalase®
2.4 L, papain, trypsin, serine, o-phthaldialdehyde (OPA),
pyrogallol, 2, 2′-azino-bis [3-ethylbenzothiazoline-6-sul-
fonic acid] (ABTS+), dimethyl sulfoxide (DMSO), ethylene-
diaminetetraacetic acid (EDTA), potassium ferricyanide
(K3Fe(CN)6), trichloroacetic acid (TCA), hippuryl-L-histi-
dyl-L-leucine (HHL), angiotensin I-converting enzyme
(ACE), sodium borate, sodium chloride, hydrochloric acid,
pyridine, benzene sulfonyl chloride (BSC), captopril, and
L-ascorbic acid were purchased from Sigma-Aldrich Chem-
ical Co. (St. Louis, MO, USA) and iron(III) chloride (FeCl3)
was obtained from Junsei Chemical Co. (Tokyo, Japan).
Protamex and flavourzyme were purchased from Novo Co.
(Novozyme Laboratories, Copenhagen, Denmark).
Enzymatic hydrolysis and fractionation of shrimp by-product
The by-products of P. borealis (PBB) were lyophilized and
stored at −20 °C until use. The crude protein content of
PBB was 44.50 ± 0.35 % by AOAC method (AOAC, 2000)
and enzymatic hydrolysis of PBB was performed using five
enzymes, alcalase, papain, trypsin, protamex, and flavour-
zyme, under their optimal conditions (Table 1). A 100-g
sample (on the basis of protein weight) and 1 % enzyme
were mixed and then the mixture was incubated for 8 h ateach optimal temperature with stirring. After incubation,
the mixture was heated at 100 °C to inactivate the enzyme.
The inactivated mixture was centrifuged at 2000×g for
20 min. After centrifugation, the supernatant was lyophi-
lized and stored at −20 °C until use.
The protamex hydrolysate (38 g) was dissolved in
50 mL deionized water and filtered by two ultrafiltration
membranes (Amicon Ultra-filter devices; Millipore, Bil-
lerica, MA, USA) with 3 and 10 kDa molecular weight
cut-offs (< 3 kDa, 3–10 kDa, and > 10 kDa). The soluble
fractions were prepared by centrifuging at 3000×g for
20 min and passed through the membrane sequentially,
beginning with the largest molecular weight cut-off mem-
brane cartridge (10 kDa). The retentate and permeate
were collected separately, and the retentate was recircu-
lated into the feed until the maximum permeate yield was
reached. Permeate from the 10 kDa membrane was then
filtered through the 3 kDa membrane with recirculation
until the maximum permeate yield was reached.
Degree of hydrolysis (DH)
The DH of enzymatic hydrolysates of PBB was cal-
culated by determining free amino groups with OPA
(Nielsen 2001).
DH ¼ h = htot  100
where htot is the total number of peptide bonds per pro-
tein equivalent, and h is the number of hydrolyzed bonds.
The factor htot is dependent on the amino acids compos-
ition of the raw material (Adler-Nissen 1986).
Total amino acids contents
The total amino acids composition was determined
using an amino acid analyzer (S43000; Sykam, Eresing,
Germany). Samples were hydrolyzed in hydrochloric acid
(6 N) in vacuum-sealed tubes at 110 °C for 24 h.
Tryptophan is measured after alkaline hydrolysis (Sato
et al. 1984). Samples (9–10 mg, 0.1 mg precision) were
dissolved in 10 mL of 4.2 N sodium hydroxide and hy-
drolysed in an oven at 110 °C for 20 h. The hydrolysates
were filtered using filter paper (ADVANTEC No. 5B)
and mass up 50 mL by 0.2 N sodium citrate buffer (pH
Table 2 The conditions of enzymatic hydrolysis and degree of
hydrolysis of the enzymatic hydrolysates of PBB
Enzyme Crude protein (%) pH Temperature (°C) DH (%)
Alcalase 70.57 ± 2.05 8.0 50 55.96 ± 0.041,d
Protamex 73.92 ± 0.95 8.0 45 59.85 ± 0.09a
Flavourzyme 67.40 ± 0.16 7.0 50 55.68 ± 0.08e
Papain 69.45 ± 1.33 6.0 37 58.86 ± 0.08b
Trypsin 66.62 ± 0.66 8.0 37 58.31 ± 0.08c
Enzymatic hydrolysates were obtained from 8 h under the optical conditions.
1Means within the same row with different superscripts are significantly
different by Duncan’s multiple range test (P < 0.05)
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70 °C. The pH of the hydrolysates was adjusted to 4.2
with 6 N HCl and 0.2 N sodium citrate buffer and mass
up 25 mL. The solutions were filtered through 0.2 μm
membrane filter and analyzed by amino acid analyzer
(Sykam 4300, Sykam, Germany).
ABTS+ radical scavenging activity
The ABTS+ radical scavenging activity was determined
using the method of Roberta et al. (1999). The ABTS so-
lution was diluted with water to achieve an absorbance
of 0.75 ± 0.03 at 734 nm. Then, 180 μL of ABTS solution
was added to 20 μL of different concentrations of sam-
ples. The mixture was incubated in the dark for 10 min
and measured the absorbance by spectrophotometer
(BIO-TEK US/MQX 200, USA) at 734 nm. L-ascorbic
acid was used as a positive control and the ABTS+ rad-
ical scavenging activity of each sample was expressed as
IC50 value.
Superoxide dismutase (SOD)-like activity
The SOD-like activity of the sample was evaluated ac-
cording to the procedure of Marklund and Marklund
(1974) with a slight modification. One hundred microli-
ters of sample solutions were mixed with 100 μL of
pyrogallol (7.2 mM) and 100 μL of 50 mM Tris-HCl
buffer at pH 8.5 containing 0.2 mM EDTA. After
10 min, 50 μL of 1 N HCl was added to the mixture to
stop the reaction and measured the absorbance at
420 nm. L-ascorbic acid was used as a positive control,
and the SOD-like activity of the PBB was expressed as
IC50 value.
Reducing power
The reducing power of shrimp shell extracts were
measured by the method of Oyaizu (1986). Different
concentrations of samples in 10 % DMSO were mixed
with 50 μL of 0.2 M sodium phosphate buffer (pH 6.6)
and 50 μL of potassium ferricyanide (10 mg/mL). The
mixtures were incubated at 50 °C for 20 min. Then,
50 μL of TCA (100 mg/mL) was added and centrifuged
at 2000×g for 10 min. After centrifugation, 100 μL of
the supernatant was mixed with 20 μL of iron(III)
chloride (1 mg/mL) and the mixture was measured at
700 nm. Reducing power was expressed as the 0.5 of
absorbance (EC50) and L-ascorbic acid was used as a
positive control.
ACE inhibitory activity
The inhibitory activity of ACE was monitored according
to the method of Li et al. (2005). A 20 μL of sample,
50 μL of 5 mM HHL, and 100 mM of sodium borate
buffer (pH 8.3) containing 300 mM NaCl were pre-
incubated at 37 °C for 5 min. The reaction was initiatedby the addition of 10 μL of ACE solution (100 mU/mL),
and the mixture was incubated at 37 °C for 30 min. The
reaction was stopped by adding 100 μL of 1 M HCl, and
then sodium borate buffer (320 μL), pyridine (600 μL),
and BSC (200 μL) were added to the reaction mixture.
After incubation at room temperature for 30 min, the
absorbance of reaction mixture was measured at 492 nm
and the captopril was used as a positive control.
Statistical analysis
The data were analyzed using analysis of variance
through the general linear model procedure (SAS Insti-
tute, Cary, NC, USA). Duncan’s multiple range test was
applied to determine the significance of the differences
between means (P < 0.05).
Results and discussion
Enzymatic hydrolysis and fractionation
Recently, the enzymatic hydrolysates have been studied
and utilized as nutraceutical resources. In particular,
the interest of many researchers on the enzymatic hy-
drolysates derived from fish and shrimp processing by-
products and the various biological activities such as
antioxidant, antibacterial, antiobesity, and antihyperten-
sive activities is growing (Sila et al. 2015; Benoit et al.
2008; Cancre et al. 1999).
In the present study, PBB was hydrolyzed by five spe-
cific enzymes including alcalase, papain, trypsin, prota-
mex, and flavourzyme for 8 h, respectively, and DH
values of their hydrolysates were given in Table 2. The
cleavage of peptide bonds by protease leads to decom-
position of protein tertiary structure and reduction of
the molecular weight of proteins (Adler-Nissen 1986).
This reaction also increases in the concentration of free
amino and carboxyl groups and its functional proper-
ties of proteins (Kristinsson and Rasco 2000). The DH
values of PBB hydrolysates were as follows: protamex
(59.85 ± 0.09 %) > papain (58.86 ± 0.08 %) > trypsin
(58.31 ± 0.08 %) > alcalase (55.96 ± 0.04 %) > flavour-
zyme (55.68 ± 0.08 %). Among the enzymatic hydroly-
sates, protamex hydrolysate of PBB showed the highest
DH value.
Table 3 Total amino acids composition for the molecular
weight cut-off fractions of protamex hydrolysate (g/100 g)
Amino acids < 3 kDa 3–10 kDa > 10 kDa
Asp 3.66 4.77 3.65
Thr 1.96 2.21 1.94
Ser 1.91 2.18 1.10
Glu 6.14 7.16 6.11
Pro 2.95 0.34 3.22
Gly 5.06 4.72 5.15
Ala 4.44 4.10 4.43
Cys 0.08 0.18 0.17
Val 2.53 2.62 2.11
Met 1.44 1.24 1.74
Ile 2.21 2.54 1.88
Leu 3.80 3.68 3.73
Tyr 1.51 1.43 1.50
Phe 2.24 2.27 2.25
His 1.29 1.73 1.24
Lys 3.06 3.49 3.89
Arg 2.94 3.36 3.07
Trp 0.22 0.15 0.30
Total 47.44 48.17 47.48
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Total amino acid composition of the three MWCO frac-
tions of protamex hydrolysate was presented in Table 3.
As shown in Table 3, the total amino acid contents of
three MWCO fractions were 47.44 g/100 g (< 3 kDa),
48.17 g/100 g (3–10 kDa), and 47.48 g/100 g (>10 kDa),
respectively. The total amino acid compositions of three
MWCO fractions were similar to each other. All
MWCO fractions were rich in Glu, Gly, Asp, Ala, Leu,
and Lys, while these fractions contained low levels of






Alcalase 0.16 ± 0.023, c 2.82 ± 0.
Protamex 0.17 ± 0.00b, c 2.04 ± 0.
Flavourzyme 0.20 ± 0.00a, b 3.13 ± 0.
Papain 0.21 ± 0.03a 2.59 ± 0.
Trypsin 0.22 ± 0.02a 2.44 ± 0.
L-Ascorbic acidA 0.004 ± 0.000d 0.02 ± 0.
CaptoprilB
1IC50 (50 % inhibitory concentration) values of ABTS
+ scavenging, SOD-like, and ACE
2The reducing power was expressed as an EC50 (concentration of the 0.5 absorbanc
3Means within the same row with different superscripts are significantly different b
A
L-ascorbic acid was used as a positive control of ABTS+ radical scavenging and SOD
BCaptopril was used as a positive control of ACE inhibitory activityAntioxidant activity
Reactive oxygen species (ROS), containing superoxide
(O2
−), hydrogen peroxide (H2O2), hydroxyl radical (OH
−),
and singlet oxygen (O2
· ), can cause the oxidative damage
to the important components such as protein, lipid, nu-
cleic acids and have been associated with the occurrence
of various diseases including hypertension (Ngo et al.
2011a, b).
The antioxidant activities of the five PBB enzymatic
hydrolysates were measured by the scavenging activity
on ABTS+ radicals, SOD-like activity, and reducing
power (Table 4). The alcalase and protamex hydroly-
sates of PBB exhibited noticeable ABTS+ radical
scavenging activity with IC50 value of 0.16 ± 0.02 and
0.17 ± 0.00 mg/mL, respectively. However, all hydro-
lysates showed lower ABTS+ radical scavenging ac-
tivity than that of L-ascorbic acid.
SOD, an important antioxidant defense enzyme, cata-
lyzes the dismutation of the superoxide anion (O2
−) into
oxygen (O2) and hydrogen peroxide (H2O2). The SOD-
like activity is widely used for assay to measure the in-
hibition of pyrogallol autoxidation. The results of SOD-
like activity of the five enzymatic hydrolysates were
shown in Table 4. The protamex hydrolysate exerted the
greatest SOD-like activity (2.04 ± 0.15 mg/mL) among
hydrolysates, while the alcalase hydrolysate exhibited
moderate activity.
The reducing power is the ability to donate an
electron or hydrogen (Dorman et al. 2003). The elec-
tron donation capacity of the five PBB enzymatic hy-
drolysates were evaluated and showed in Table 4. All
the PBB hydrolysates exhibited moderate reducing
power.
The antioxidant activities of the three MWCO frac-
tions of protamex hydrolysate were evaluated and
showed in Table 5. The < 3 kDa and 3–10 kDa frac-
tions showed potent ABTS+ radical scavenging activity








72a 9.42 ± 0.82a 0.11 ± 0.01b
15a 6.75 ± 0.94b 0.08 ± 0.00c
51a 4.63 ± 0.15c 0.11 ± 0.00b
48a 4.46 ± 0.31c 0.11 ± 0.01b
13a 6.62 ± 0.06b 0.13 ± 0.00a
00b 0.04 ± 0.00d
0.00002 ± 0.00000d
inhibitory activities were expressed as a mean ± SD
e) value
y Duncan’s multiple range test (P < 0.05)
-like activities and reducing power
Table 5 Antioxidant and ACE inhibitory activities for the molecular weight cut-off fractions of the protamex hydrolysate
Sample ABTS+ scavenging activity SOD-like activity Reducing power ACE inhibitory activity
IC50 (mg/mL)
1 IC50 (mg/mL) EC50 (mg/mL)
2 IC50 (mg/mL)
< 3 K 0.22 ± 0.013, b >10 20.14 ± 0.39a 0.06 ± 0.00a
3–10 K 0.22 ± 0.00b >10 13.84 ± 0.16b 0.03 ± 0.00b
> 10 K 0.24 ± 0.01a >10 7.04 ± 0.83c 0.03 ± 0.00b
L-Ascorbic acidA 0.005 ± 0.000c 0.07 ± 0.00d 0.04 ± 0.00d
CaptoprilB 0.00001 ± 0.0000c
Antioxidant and ACE inhibitory activities were measured using the molecular weight cut-off fractions of the protamex hydrolysate
1IC50 values of ABTS
+ scavenging, SOD-like, and ACE inhibitory activities were expressed as a mean ± SD
2The reducing power was expressed as an EC50 value
3Means within the same row with different superscripts are significantly different by Duncan’s multiple range test (P < 0.05)
A
L-ascorbic acid was used as a positive control of ABTS+ radical scavenging and SOD-like activities, and reducing power
BCaptopril was used as a positive control of ACE inhibitory activity
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ducing power with EC50 value of 7.04 ± 0.83 mg/mL
than those of the < 3 kDa and 3–10 kDa fractions.
However, the three MWCO fractions showed not high
antioxidant activities as much as protamex enzymatic
hydrolysate.
ACE inhibitory activity
The inhibition of ACE, a key enzyme regulating the
blood pressure, has been recognized as the most effect-
ive therapy for the treatment of hypertension. However,
many synthetic ACE inhibitors including captopril,
enalapril, alacepril, fosinopril, and lisinopril cause side
effects such as cough, taste alterations, skin rashes, and
angioneurotic edema (Alderman 1996; Cicoira et al.
2001; Vyssoulis et al. 2001). Therefore, it is necessary
to develop safe and effective ACE inhibitors from nat-
ural products.
The ACE inhibitory activity of the enzymatic hy-
drolysates of PBB was shown in Table 4. Among the
five PBB hydrolysates, the protamex hydrolysate ex-
hibited the most potent ACE inhibitory activity with
IC50 value of 0.08 ± 0.00 mg/mL, followed by flavour-
zyme (IC50 = 0.11 ± 0.00 mg/mL) > alcalase (IC50 =
0.11 ± 0.01 mg/mL) > papain (IC50 = 0.11 ± 0.00 mg/mL) >
trypsin (IC50 = 0.13 ± 0.00 mg/mL).
The ACE inhibitory activity of the three MWCO frac-
tions of protamex hydrolysate was measured and shown
in Table 5. Among the MWCO fractions, the > 3 kDa
fraction including 3–10 kDa and > 10 kDa fractions
showed significant ACE inhibitory activity with IC50
value of 0.03 ± 0.00 mg/mL. This result also indicated that
high molecular weight fraction, 3–10 kDa and > 10 kDa,
exhibited potent ACE inhibitory activity compared with
protamex enzymatic hydrolysate.
Recently, many researchers have reported that vari-
ous bioactive peptides derived from fisheries process-
ing by-products including crab shell (Yoon et al.
2013), Pacific cod skin (Ngo et al. 2011a, b), squidskin and muscle (Mendis et al. 2005; Rajapakse et al.
2005), and tuna (Qian et al. 2007; Je et al. 2005; Lee
et al. 2010). In the present study, PBB protamex hy-
drolysate showed notable ABTS+ radical scavenging
and ACE inhibitory activities. In addition, its MWCO
fractions exerted potent ACE inhibitory activities.
Therefore, more detailed investigations are necessary
to isolate and identify the peptides from active en-
zymatic hydrolysate and to clarify the mechanism of
active peptides.
Conclusions
In this study, the five enzymatic hydrolysates of PBB de-
rived from fisheries processing by-products were investi-
gated on the antioxidant and ACE inhibitory activities.
The PBB Protamex hydrolysate which showed the most
potent ACE inhibitory activity than other fractions was
fractionated as the below 3 kDa, between 3 and 10 kDa,
and above 10 kDa fractions respectively to isolate the ac-
tive materials. But these fractions showed lower antioxi-
dant activities than those of enzymatic hydrolysate, while
these fractions showed the significant ACE inhibitory
activity. In addition, 3-10 kDa and >10 kDa fractions
showed the better ACE inhibitory activity than <3 kDa
fraction. These results suggested that the high molecular
weight enzymatic hydrolysate derived from PBB could
be used for prevent hypertension.
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